Suchergebnisse - "Humans"

PubPharm (6.335)

1

Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance

enthalten in: Nature cancer | 2024

von Zheng, H. | Liu, J. | Cheng, Q. | +19

2

Clinical Pharmacology of the Antibody-Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors

enthalten in: Clinical pharmacokinetics | 2024

von Tang, M. | Garg, A. | Bonate, P. | +14

3

Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model

enthalten in: Clinical & experimental metastasis | 2024

von Pourjamal, N. | Yazdi, N. | Halme, A. | +5

4

CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells

enthalten in: Cancer biology & therapy | 2024

von Wang, H. | Koob, T. | Fromm, J. | +3

5

Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells

enthalten in: Nature | 2024

von Guan, X. | Hu, R. | Choi, Y. | +28

ErratumIn: Nature. 2024 Mar 13;:. - PMID 38480897

6

Production and characterization of a camelid single domain anti-CD22 antibody conjugated to DM1

enthalten in: Molecular and cellular biochemistry | 2024

von Ziaei, V. | Ghassempour, A. | Davami, F. | +4

7

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

enthalten in: The New England journal of medicine | 2024

von Powles, T. | Valderrama, B. | Gupta, S. | +122

8

Toxicology, pharmacokinetics, and immunogenicity studies of CCR4-IL2 bispecific immunotoxin in rats and minipigs

enthalten in: European journal of pharmacology | 2024

von Wang, Z. | Ramakrishna, R. | Wang, Y. | +12

9

177Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models

enthalten in: European journal of nuclear medicine and molecular imaging | 2024

von Zeng, Z. | Li, L. | Tao, J. | +5

10

Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors

enthalten in: Clinical and translational science | 2024

von Robbrecht, D. | Grob, J. | Bechter, O. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[634]